Article

Galectin-3: a novel biomarker of glycogen storage disease type III

2024-12-18

Abstract excerpt

<title>Abstract</title> <p>Glycogen storage disease type III (GSDIII) is a rare genetic disorder leading to abnormal glycogen storage in liver and skeletal muscle. In this study, we conducted a comparative gene expression analysis of several <italic>in vitro</italic> and <italic>in vivo</italic> models identifying galectin-3 as a potential biomarker of the disease. Interestingly, we also observed a significant de...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: bb289345-0fd6-55ec-908c-e58391f50a82
DOI: 10.21203/rs.3.rs-5216196/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Galectin-3: a novel biomarker of glycogen storage disease type IIIDOI 10.21203/rs.3.rs-5216196/v1Read

Distinct Clinical and Genetic Findings in Iranian Patients With Glycogen Storage Disease Type 3.Semantic proximity Read

[Glycogen storage disease type Ib].Semantic proximity Read

Gene therapy for glycogen storage diseasesSemantic proximity Read

A Rare Case of Glycogen Storage Disease Type IIIa with a Novel Homozygous AGL Splice Variant in a Two-Year-Old Female born out of Consanguineous MarriageSemantic proximity Read

Molecular characterization of glycogen storage disease type III.Semantic proximity Read

Proteomics profiling of serum and liver in GSD Ia and Ib patients: insights into complication mechanisms and circulation biomarkersSemantic proximity Read

Rescue of GSDIII Phenotype with Gene Transfer Requires Liver- and Muscle-Targeted GDE Expression.Semantic proximity Read

Galectin-3 and <i>N</i> -acetylglucosamine promote myogenesis and improve skeletal muscle function in the <i>mdx</i> model of Duchenne muscular dystrophySemantic proximity Read

Gene therapy for glycogen storage diseasesSemantic proximity Read

CRISPR/Cas9 ‐based double‐strand oligonucleotide insertion strategy corrects metabolic abnormalities in murine glycogen storage disease type‐IaSemantic proximity Read

Molecular biology and gene therapy for glycogen storage disease type Ib.Semantic proximity Read

Cytokeratin 8 Inhibits Hepatic Glycogen Synthesis in Type 2 Diabetes Mellitus by Modulating Insulin-dependent IRS1/PI3K/Akt-GSK3β PathwaySemantic proximity Read